Moneycontrol
HomeNewsBusinessCompaniesElder Pharma eyes Rs 100cr from global sales of Shelcal
Trending Topics

Elder Pharma eyes Rs 100cr from global sales of Shelcal

Elder had sold Shelcal's domestic market rights and 30 other brands to Torrent Pharma last year for Rs 2,000 crore but had retained the rights for the international markets.

June 14, 2015 / 12:53 IST
Story continues below Advertisement

Elder Pharmaceuticals is targeting Rs 100 crore from global sales of its calcium supplement brand Shelcal by 2017-18, in view of increasing exports base to Europe, Asia and African countries.

Elder had sold Shelcal's domestic market rights and 30 other brands to Torrent Pharma last year for Rs 2,000 crore but had retained the rights for the international markets.

Story continues below Advertisement

"We now plan to do aggressive marketing of this superbrand globally and going by the response received so far, we expect that the company should be able to garner a turnover of about Rs 100 crore from the International operations of Shelcal by 2017-18," Elder Pharmaceuticals Chairman and Managing Director Alok Saxena told PTI here.

The company is also looking to export another nutritional product, Thrive, a natural supplement that helps fight chronic metabolic disorders, he added.